Related references
Note: Only part of the references are listed.Safety and effectiveness of up to 3 years' bulevirtide monotherapy in patients with HDV-related cirrhosis
Alessandro Loglio et al.
JOURNAL OF HEPATOLOGY (2022)
Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg
Louis Shekhtman et al.
SCIENTIFIC REPORTS (2020)
Response guided therapy for reducing duration of direct acting antivirals in chronic hepatitis C infected patients: a Pilot study
Ohad Etzion et al.
SCIENTIFIC REPORTS (2020)
Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo
Katja Giersch et al.
GUT (2019)
The use of humanized mice for studies of viral pathogenesis and immunity
Florian Douam et al.
CURRENT OPINION IN VIROLOGY (2018)
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial
Christopher Koh et al.
LANCET INFECTIOUS DISEASES (2015)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
Understanding Early Serum Hepatitis D Virus and Hepatitis B Surface Antigen Kinetics During Pegylated Interferon-alpha Therapy Via Mathematical Modeling
Jeremie Guedj et al.
HEPATOLOGY (2014)